*Sponsored by Lifewater Media. Please see disclosures below. |
| Put "ISPC" on Your Radar! |
| | | | | Folks, Get ready for another juicy idea! iSpecimen runs a sophisticated marketplace connecting researchers to patients, biospecimens, and data, through their global network. | | | Why is this a big deal? Because there may be an opportunity to tap into an underdeveloped market that connects "providers" with "researchers". This includes people working in the biotech sector such as informaticists, principle investigators and scientists. | | | iSpecimen likely has the necessary technology infrastructure in order to take advantage of this industry gap... In fact, they seem to already be taking advantage! According to the company, there is a large and growing data set that has been collected, including 80+ million clinical specimens, 15+ million patient records, 640+ million laboratory test records, etc. | | | Here's where things get interesting! A large database of information may open doors for new potential revenue streams for iSpecimen. Third party information is valuable in any industry, especially biotech, where products are often sold at a financial premium. While there are no guarantees that the company will take advantage, it is likely something that investors and speculators will be eyeing. | | | The company also maintains a robust international presence through agreements with over 140 supplier organizations across various countries. This includes the United States, UK, Germany, India, Netherlands, and Turkey among others. I wouldn't be surprised if additions to this list have an impact on ISPC given how low the float is currently... | | | Only 0.65 million according to Finviz! It may also explain why the stock has had such a strong proof of spikeability over the past seven months or so. ISPC rallied many times, hitting highs of $14.8 (according to ThinkorSwim) as well as multiple pushes above $11. | | | Now, just because it has happened in the past does not mean it will happen again, but it is something to pay attention to moving forward. Anyways...
That's all for now! Until Next Time, -Damian |
|
|
|---|
|
*Sponsored by Lifewater Media. Please see disclosures below. |
|
|---|
|
| | 5101 SANTA MONICA BLVD STE 8 #62, 90029, LOS ANGELES, CA |
| You've received it because you've subscribed to our newsletter or are a member of ZipTraderU. |
| This email was sent to edwardlorilla1986.paxforex@blogger.com |
| *SPONSORED CONTENT* ZipTrader LLC is a publishing company, we are not financial advisors. This is not financial advice. Investments involve risk and are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance. ZipTrader has been compensated thirty-two thousand USD by ACH Bank Transfer by Lifewater Media to distribute media via email, SMS, Discord, Facebook, and X/Twitter for iSpecimen Inc. (ISPC) from November 6, 2024 to November 7, 2024. ZipTrader may receive additional campaigns in the future by Lifewater Media to distribute media for iSpecimen Inc. (ISPC). As a result of this advertisement and other marketing efforts, ZipTrader may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of this advertisement, the owners of ZipTrader do not hold a position in iSpecimen Inc. (ISPC). This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of iSpecimen Inc. (ISPC), increased trading volume, and possibly an increased share price of iSpecimen Inc. (ISPC), which may or may not be temporary and decrease once the marketing arrangement has ended. |
| BY READING THIS EMAIL & ALL ZIPTRADER CONTENT YOU AGREE: This is not financial advice. You must do your own due diligence on all information. ZIPTRADER LLC is a publishing company and we provide general information, opinions, & news coverage to viewers. However – we do not provide personalized financial advice, are not financial advisors, and our opinions are not suitable for all investors. You should not treat any opinion as expressed as a specific inducement to make a particular investment or follow a particular strategy, but just as an opinion. Use at your own risk. Past Performance is not indicative of future results, and any results presented are not typical, and should not be understood as typical. Actual results vary given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. TRADING IS RISKY: Most traders in all markets lose all of their money (and more if they use margin). Most small businesses fail. Do NOT partake in trading, investing, entrepreneurship or any other risky endeavor covered here if you are not prepared with the reality that most fail. We reserve the right to have affiliate relationships with advertisers/sponsors. See Full Terms of Service.See Our Advertisement/Sponsored Stock Disclaimer. |
| | |
|
|
|---|
|
|
|
No comments:
Post a Comment